Stockscreener 앱 받기
0.916
4.69%
-0.0451
시간 외 거래:
.92
0.004
+0.44%
전일 마감가:
$0.9611
열려 있는:
$0.975
하루 거래량:
310.91K
Relative Volume:
5.46
시가총액:
$2.80M
수익:
$7.15M
순이익/손실:
$4.03M
주가수익비율:
-0.1696
EPS:
-5.4
순현금흐름:
$-11.33M
1주 성능:
-4.64%
1개월 성능:
-71.10%
6개월 성능:
-87.93%
1년 성능:
-87.93%
1일 변동 폭
$0.915
$1.04
1주일 범위
$0.8225
$1.05
52주 변동 폭
$0.8225
$3.88
Trxade Health Inc Stock (MEDS) Company Profile
명칭
Trxade Health Inc
전화
(800) 261 0281
주소
2420 BRUNELLO TRACE, LUTZ, FL
Compare MEDS vs HITI, PETS, SCNX, POM, RDGT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MEDS
Trxade Health Inc
|
0.916 | 4.44M | 7.15M | 4.03M | -11.33M | -5.40 |
HITI
High Tide Inc
|
2.565 | 215.28M | 486.49M | -33.29M | 10.86M | -0.3627 |
PETS
Petmed Express Inc
|
1.81 | 38.15M | 179.02M | -57.29M | -33.01M | -2.7487 |
SCNX
Scienture Holdings Inc
|
0.373 | 19.37M | 656.60K | -16.79M | -11.12M | -1.0743 |
POM
Pomdoctor Ltd Adr
|
0.83 | 7.61M | 0 | 0 | 0 | 0.00 |
RDGT
Ridgetech Inc
|
0.9081 | 2.92M | 111.62M | 762.70K | 16.36M | -85.73 |
Trxade Health Inc 주식(MEDS)의 최신 뉴스
Scienture Holdings Reports Q2 2026 Results, Launches REZENOPY™ and Narrows Losses - Quiver Quantitative
Wellgistics Health Inc. (MEDS) Live Share Price, Invest From India - INDmoney
WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC. - Stock Titan
SCNXScienture Holdings Inc Stock Price and Quote - Finviz
Trxade Health announces name change to Scienture Holdings - Intellectia AI
MEDS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - Intellectia AI
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - Intellectia AI
MEDS Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
MEDS News & Events - Intellectia AI
Wellgistics Health Taps Former Optum, Evernorth Executives in Major Leadership Overhaul for Digital Transformation - Stock Titan
SCIENTURE Appoint Dr. Shankar Hariharan and Dr. Narasimhan Mani as Co-CEO’s - citybiz
Integra Pharma Solutions, LLC (d/b/a TRxADE Prime(TM) (a TRxADE HEALTH Company) Secures Preferred Distribution Agreement with GALT Pharmaceuticals, LLC - ACCESS Newswire
TRxADE Group, Inc. Announces Name Change to TRxADE HEALTH, INC. - ACCESS Newswire
Datameds AI (MEDS) Stock Price, News & Analysis - Stock Titan
Bonum Health(TM), LLC (a TRxADE HEALTH Company) Reaffirms its Commitment to Independent Pharmacies and Group Purchasing Organizations (GPOs) with its Novel Telemedicine Services Model - ACCESS Newswire
Oragenics Appoints Janet Huffman As Interim CEO - citybiz
Urgent Company Parent Co. Sued By Eat Well Investment Group - Nosh.com
Group Alleges $10M 'Sham' In Fla. Plant-Based Co. Stock Deal - Law360
UK Compounding Pharmacies Market Size & Outlook, 2023-2030 - Grand View Research
TRxADE HEALTH (NASDAQ: MEDS)Share Price - intelligentinvestor.com.au
TRxADE Health changes its name to Scienture Holdings - AlphaStreet
MEDS Price History for Trxade Health Stock - Barchart.com
Trxade Health (MEDS) Q2 2024 Research Summary - AlphaStreet
TRxADE HEALTH, INC 10-Q Report - TradingView
About Us - FinancialContent
Dykema Guides TRxADE in Another Acquisition - Dykema
Tampa pharma company stacked with former McKesson execs launches IPO - The Business Journals
MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results - AlphaStreet
TRxADE HEALTH (MEDS) Stock News & Updates - Stock Titan
TRxADE HEALTH, INC. Releases Q1 2024 10-Q Report Highlighting Strategic Shifts and Financial Performance - TradingView
Trxade Group Confronts Compliance Issues and Board Changes - TipRanks
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary - AlphaStreet
TRxADE HEALTH, INC. Releases 10-K Report Highlighting Financial and Strategic Developments - TradingView
TRxADE Health, Inc. Announces Special Cash Dividend - Stock Titan
Trxade Health Surges 40% On Special Dividend - RTTNews
Why Is Trxade Health (MEDS) Stock Up 230% Today? - InvestorPlace
Dykema Completes Sale of Assets for TRxADE Health, Inc. - Dykema
MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results - AlphaStreet
TRxADE HEALTH, INC. Releases Q3 10-Q Report Highlighting Strategic Shifts and Financial Performance - TradingView
Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry. - Yahoo Finance
Food technology company prepares to enter plant-based pet nutrition market - Pet Food Processing
The Week in AgriFoodTech: Toyota does indoor farming, Bayer & Pairwise ink deal, cultivated seafood gets big in Japan - AgFunderNews
Superlatus into snacks with protein twists - Food Business News
Perfect Day Agrees To Sell D2C Arm The Urgent Company for $1.25M - Green Queen Media
Trxade Health (MEDS) Stock Is Moving Higher: What's Going On? - Benzinga
Twilio (TWLO) Earnings: 2Q23 Key Numbers - AlphaStreet
Artemis Strategic (ARTE) to Combine with Danam Health in $200M Deal - SPACInsider
TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc. - GlobeNewswire
Superlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive Merger Agreement to Create a Global Strategic Platform for Food and Healthy Snack Marketplace and Distribution - Yahoo Finance
Trxade Health up 68%this time it’s a real price movement on a reverse takeover - Dhaka Tribune
Trxade Health Inc (MEDS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.77%
4.55%
자본화:
|
볼륨(24시간):